Subscribe free!

Find out why we're the #1 free penny stock alert newsletter


NASDAQ Stock Telik Inc. (TELK) Surges in Thursday’s Session

| |

Shares of Telik Inc. (NASDAQ: TELK), a clinical-stage drug development company engaged in the discovery and development of small molecule drugs to treat cancer, surged in Thursday’s trading session.

The small-cap stock of TELK ended the day 29.79% higher at $5.62. The stock extended its gains in after-hours trading on Thursday, rising more than 4%.

Earlier this month, Telik announced its first-quarter 2012 financial results. TELK reported net loss of $2.3 million for the three-month period ended March 31, 2012. This compares with a net loss of $3.7 million, or $2.05 per share reported for the same period in the previous year.

Posted by on Friday, May 25th, 2012. Filed under Gadgets, Stocks. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Leave a Reply